The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In the Archives

Presidents Day, Black History Month, Lasker Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

This column in The Cancer Letter features the latest posts to the Cancer History Project by our growing list of contributors.

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available.

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj.

Upcoming

Finding the cure for childhood leukemia: On Feb. 24, a Buffalo Public Library panel featuring Jerry Yates, Mary Pinkel, and Cancer History Project editorial board member Tim Wendel.

Register in advance on Zoom.

Quote of the week

It is a great human weakness to generalize from exceptions. As scientists, we know that the best solution to a specific problem is a specific solution.

Emil J Freireich

Freireich’s Seven Laws To Protect Against Obstacles To Clinical Research
The Cancer Letter, May 14, 1976

Black History Month

jane-wright

A collection of posts celebrating the impact on oncology by Black, Indigenous, and People of Color oncologists, researchers, and advocates will continue to be available under the tag “BIPOC Impact.”

Presidents Day

These articles were highlighted on Presidents Day via @CancerHistProj on Twitter as part of a series on cancer in the White House.

Recent contributions

Is your institution a contributor to the Cancer History Project? Would you like us to tell you about the project and how you can get involved?

Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. To apply to become a contributor, please contact admin@cancerhistoryproject.com.

Table of Contents

YOU MAY BE INTERESTED IN

ClinicalTrials & Tribulations

Saving Western Kenya’s pediatric blood cancer patients
How flow cytometry is changing the diagnostic landscape

When our hematological malignancy testing pilot project began in Eldoret, Kenya, there seemed to be a mismatch in relation to progress in healthcare. The region, like much of sub-Saharan Africa, had been focusing on combatting infectious diseases such as HIV and malaria—which was much-needed—yet cancer care was under-resourced. 
By Samuel (Tony) Boova, Eda Holl, LaToya Montgomery, Steve Kussick, Nicholas Kigen, Gilbert Olbara, Festus Muigai Njuguna, Terry Vik and Teresa Loile Lotodo
ClinicalTrials & Tribulations

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research. 
By Enrique Velazquez-Villarreal
Sponsored

The long life of a clinical trial
How JCO sustains landmark oncology research

In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure. 
By Journal of Clinical Oncology
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account